Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,653,614 papers from all fields of science
Search
Sign In
Create Free Account
ketanserinol
Known as:
2,4(1H,3H)-Quinazolinedione, 3-(2-(4-((4-fluorophenyl)hydroxymethyl)-1-piperidinyl)ethyl)-
, 3-(2-(4-((4-fluorophenyl)hydroxymethyl)-1-piperidinyl)ethyl)-2,4-(1H,3H)quinazolinedione
, reduced ketanserin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Ketanserin
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Ketanserin in pre‐eclamptic patients: transplacental transmission and disposition in neonates
L. Hanff
,
W. Visser
,
+4 authors
A. Vulto
BJOG: an International Journal of Obstetrics and…
2004
Corpus ID: 10265809
The aim of this prospective, observational study was to assess transplacental transmission of ketanserin, an antihypertensive…
Expand
2003
2003
Simultaneous quantitative analysis of ketanserin and ketanserinol in plasma by RP-HPLC with fluorescence detection.
A. Yassen
,
L. Hanff
,
A. Vulto
Biomedical chromotography
2003
Corpus ID: 34904589
A sensitive and selective high-performance liquid chromatographic assay for the quantification of ketanserin and ketanserinol in…
Expand
2000
2000
The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits.
R. Schoenwald
,
J. Zhu
Journal of Ocular Pharmacology and Therapeutics
2000
Corpus ID: 23433745
Ketanserin, a hypotensive drug with 5-HT2 receptor antagonism, when administered by topical infusion of a 0.25% w/v solution by…
Expand
1990
1990
Pharmacokinetics of Ketanserin in Patients with Cirrhosis
D. Lebrec
,
A. Hadengue
,
+4 authors
J. Benhamou
Clinical Pharmacokinetics
1990
Corpus ID: 8027472
SummaryThe pharmacokinetics of ketanserin, a new serotonin S2 (5HT2) antagonist, were studied in 26 patients with cirrhosis…
Expand
1988
1988
Prolongation of the QT interval by ketanserin.
H. A. Cameron
,
P. Waller
,
L. Ramsay
Postgraduate medical journal
1988
Corpus ID: 40440325
In hypertensive patients single doses of ketanserin 40 mg prolonged the corrected QT interval (QTc) for at least 8 hours, with a…
Expand
1988
1988
Prolongation oftheQTinterval byketanserin
H. A. Cameron
,
P. Waller
,
E. Ramsay
1988
Corpus ID: 76564676
Summary:Inhypertensive patients single doses ofketanserin 40mgprolonged thecorrected QT interval (QT)foratleast 8hours…
Expand
1987
1987
Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
H. A. Cameron
,
P. Waller
,
L. Ramsay
British Journal of Clinical Pharmacology
1987
Corpus ID: 11874172
1. The antihypertensive efficacy and tolerability of twice-daily treatment with the 5-hydroxytryptamine antagonist ketanserin…
Expand
1987
1987
The interactions of propranolol and ketanserin
H. Ochs
,
D. Greenblatt
,
M. Höller
,
L. Labedzky
Clinical pharmacology and therapy
1987
Corpus ID: 23496463
Ten healthy volunteers received a single 10 mg intravenous dose of the 5‐hydroxytryptamine‐2 serotonin antagonist ketanserin in…
Expand
1985
1985
Simultaneous determination of ketanserin and ketanserinol in biological fluids using ion-pair liquid chromatography and fluorometric detection.
M. Kurowski
Journal of Chromatography A
1985
Corpus ID: 43328529
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required